期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 186, 期 3, 页码 E41-E44出版社
WILEY
DOI: 10.1111/bjh.15888
关键词
multiple myeloma; pembrolizumab; PD-1 (PDCD1)
类别
资金
- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA